The effect of oral and intravenous methylprednisolone treatment on subsequent relapse rate in multiple sclerosis.

The effect of oral and intravenous methylprednisolone treatment on subsequent relapse rate in multiple sclerosis.

We investigated the effect of oral and intravenous methylprednisolone treatment on subsequent relapse rate in patients with multiple sclerosis. Following a double blind trial designed to compare the effect of oral and intravenous methylprednisolone treatment on promoting recovery from acute relapses...

Full description

Bibliographic Details
Main Authors:	Sharrack, B, Hughes, R, Morris, R, Soudain, S, Wade-Jones, O, Barnes, D, Brown, P, Britton, T, Francis, D, Perkin, G, Rudge, P, Swash, M, Katifi, H, Farmer, S, Frankel, J
Format:	Journal article
Language:	English
Published:	2000

Similar Items

Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis.
by: Barnes, D, et al.
Published: (1997)

Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease
by: Carmen Lienert, et al.
Published: (2013-05-01)

Satisfaction, Safety and Cost of the Treatment for Multiple Sclerosis Relapse with Intravenous versus Oral Methylprednisolone
by: Montserrat Gonzalez-Platas, et al.
Published: (2018-10-01)

Oral versus intravenous methylprednisolone for the treatment of multiple sclerosis relapses: A meta-analysis of randomized controlled trials.
by: Shuo Liu, et al.
Published: (2017-01-01)

Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations
by: Yassouridis Alexander, et al.
Published: (2006-05-01)

Leprosy neuropathy: administration of intravenous methylprednisolone pulsotherapy
by: MARIA LÚCIA VELLUTINI PIMENTEL
Published: (2002-09-01)

Safety of Intravenous Methylprednisolone in Refractory and Severe Pediatric Uveitis
by: Ghoraba HH, et al.
Published: (2022-05-01)

Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses
by: Steffen Pfeuffer, et al.
Published: (2022-09-01)

High dose intravenous methylprednisolone in the treatment of severe acute respiratory syndrome.
by: Mishra, S, et al.
Published: (2004)

Intravenous methylprednisolone could salvage vision in methyl alcohol poisoning
by: Shukla Manoj, et al.
Published: (2006-01-01)

Benefits of early treatment with intravenous methylprednisolone in recurrent posterior scleritis
by: Anupama Bappal, et al.
Published: (2014-01-01)

Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosis.
by: Adi Wilf-Yarkoni, et al.
Published: (2023-01-01)

Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosis
by: Adi Wilf-Yarkoni, et al.
Published: (2023-01-01)

Effect of Intravenous Methylprednisolone on Pain after Intertrochanteric Femoral Fracture Surgery
by: Poupak Rahimzadeh, et al.
Published: (2014-04-01)

Intravenous methylprednisolone in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP)
by: Abelardo Q-C Araújo, et al.
Published: (1993-09-01)

The Effect of Pulse Methylprednisolone Plus Theophylline Treatment on Clinical, Pulmonary and Inflammatory Markers in Relapses of Multiple Sclerosis
by: Pervin İşeri, et al.
Published: (2013-03-01)

Pulmonary hemorrhage associated with severe leptospirosis – the role of low dose intravenous methylprednisolone
by: Lim, Christopher Thiam Seong, et al.
Published: (2018)

The Utility of Intravenous Methylprednisolone as an Adjunct Treatment for Drug-Resistant Amiodarone-Induced Thyrotoxicosis
by: Krzysztof Cezary Lewandowski, et al.
Published: (2024-01-01)

Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves’ orbitopathy
by: Dorota Walasik-Szemplińska, et al.
Published: (2019-12-01)

Modeling Pathway Dynamics of the Skeletal Muscle Response to Intravenous Methylprednisolone (MPL) Administration in Rats: Dosing and Tissue Effects
by: Alison Acevedo, et al.
Published: (2020-07-01)

Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC)
by: S. R. M. Bus, et al.
Published: (2021-02-01)

Methylprednisolon acetate in the management of
by: N. Khaci, M.D., et al.
Published: (2008-01-01)

Prognosis of Taiwanese Patients with Isolated Optic Neuritis After Intravenous Methylprednisolone Pulse Therapy
by: Yo-Chen Chang, et al.
Published: (2007-08-01)

Methylprednisolone versus intravenous immune globulin as an initial therapy in adult primary immune thrombocytopenia
by: Chul Hee Kim, et al.
Published: (2019-03-01)

Expression of the chemokines CXCL10 and CCL2 in serum and cerebrospinal fluid of patients with multiple sclerosis treated with intravenous methylprednisolone
by: Marcos Moreira
Published: (2004-09-01)

Analysis of risk factors of liver injury after intravenous methylprednisolone in neuromyelitis optica spectrum disorders
by: YANG Qing⁃lin, et al.
Published: (2022-09-01)

Impact of additional intravenous methylprednisolone pulse therapy on the quality of life in patients with dysthyroid optic neuropathy
by: Maryla Pelewicz, et al.
Published: (2021-06-01)

Allergy to methylprednisolone
by: Ana Josefa Pérez-Aragón, et al.
Published: (2019-07-01)

Clinical experience with repository corticotropin injection in patients with multiple sclerosis experiencing mood changes with intravenous methylprednisolone: a case series
by: Stacey Murray, et al.
Published: (2016-05-01)

Thyroid stimulating immunoglobulin concentration is associated with disease activity and predicts response to treatment with intravenous methylprednisolone in patients with Graves’ orbitopathy
by: Gijsbert J. Hötte, et al.
Published: (2024-03-01)

Dose Intensive Rituximab and High-Dose Methylprednisolone in Elderly or Unfit Patients with Relapsed Chronic Lymphocytic Leukemia
by: Regina Pileckyte, et al.
Published: (2019-10-01)

Comparative study of intravenous methylprednisolone pulse therapy versus oral prednisolone minipulse therapy in progressive vitiligo
by: K A Rajeshwari, et al.
Published: (2023-01-01)

Success Treatment of Severe and Active Graves’ Orbitopathy with Tocilizumab After Thyroidectomy and Maximum Dose of Intravenous Methylprednisolone
by: Laurentius Aswin Pramono
Published: (2023-10-01)

Decrease in Bone Formation and Bone Resorption during Intravenous Methylprednisolone Pulse Therapy in Patients with Graves’ Orbitopathy
by: Joanna Rymuza, et al.
Published: (2022-08-01)

Short-term outcome of intravenous methylprednisolone pulse therapy versus oral prednisolone in patients with epileptic spasms
by: Abdelsattar Abdullah Elsayeh, et al.
Published: (2022-03-01)

Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better?
by: Tao-Ran Li, et al.
Published: (2020-03-01)

Severe Adult Still’s Disease Complicated by Purtscher-Like Retinopathy Treated with Intravenous Pulse Methylprednisolone and Tocilizumab
by: Kaho Akiyama, et al.
Published: (2021-06-01)

A case of ANA-negative systemic sclerosis treated with methylprednisolone
by: Carminda P. Rogacion, et al.
Published: (2019-12-01)

Methylprednisolone stimulated gene expression (GILZ, MCL-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical response
by: Maria Eleftheria Evangelopoulos, et al.
Published: (2021-09-01)

Efficacy and safety of intravenous methylprednisolone in the treatment of patients with active ankylosing spondylitis: Results of a 12-week, prospective, open-label, pilot (METALL) study
by: I Z Gaydukova, et al.
Published: (2015-05-01)